Oyindamola Adebayo

Ms. Oyindamola Adebayo


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 June 2021 in Cells
Verified
Journal Article
Open access
PDF file
Tjessa BondueTjessa Bondue
Tjessa Bondue
FAFanny Oliveira Arcolino
Fanny Oliveira Arcolino
KVKoenraad Veys
Koenraad Veys
OAOyindamola Adebayo
Oyindamola Adebayo
ELElena Levtchenko
Elena Levtchenko
Mohamed A. ElmonemMohamed A. Elmonem
Mohamed A. Elmonem
Epithelial cells exfoliated in human urine can include cells anywhere from the urinary tract and kidneys; however, podocytes and proximal tubular epithelial cells (PTECs) are by far the most relevant cell types for the study of genetic kidney diseases. When maintained in vitro, they have been proven extremely valuable for discovering disease mechanisms and for the development of new therapies. Furthermore, cultured patient cells can individually represent their human sources and their specific variants for personalized medicine studies, which are recently gaining much interest. In this review, we summarize the methodology for establishing human podocyte and PTEC cell lines from urine and highlight their importance as kidney disease cell models. We explore the well-established and recent techniques of cell isolation, quantification, immortalization and characterization, and we describe their current and future applications.

28 July 2021 in Cells
Verified
Journal Article
Open access
PDF file
PMPepe EKULU MFUTU
Pepe EKULU MFUTU
OAOyindamola Adebayo
Oyindamola Adebayo
JDJean-Paul Decuypere
Jean-Paul Decuypere
LBLinda Bellucci
Linda Bellucci
Mohamed A. ElmonemMohamed A. Elmonem
Mohamed A. Elmonem
ELElena Levtchenko
Elena Levtchenko
Apolipoprotein L1 (APOL1) high-risk genotypes (HRG), G1 and G2, increase the risk of various non-diabetic kidney diseases in the African population. To date, the precise mechanisms by which APOL1 risk variants induce injury on podocytes and other kidney cells remain unclear. Trying to unravel these mechanisms, most studies have used animal or cell models created by gene editing. We developed and characterised conditionally immortalised human podocyte cell lines derived from urine of a donor carrying APOL1 HRG G2/G2. Following induction of APOL1 expression by polyinosinic-polycytidylic acid (poly(I:C)), we assessed functional features of APOL1-induced podocyte dysfunction. As control, APOL1 wild type (G0/G0) podocyte cell line previously generated from a Caucasian donor was used. Upon exposure to poly(I:C), G2/G2 and G0/G0 podocytes upregulated APOL1 expression resulting in podocytes detachment, decreased cells viability and increased apoptosis rate in a genotype-independent manner. Nevertheless, G2/G2 podocyte cell lines exhibited altered features, including upregulation of CD2AP, alteration of cytoskeleton, reduction of autophagic flux and increased permeability in an in vitro model under continuous perfusion. The human APOL1 G2/G2 podocyte cell model is a useful tool for unravelling the mechanisms of APOL1-induced podocyte injury and the cellular functions of APOL1.

3 March 2026 in Scientific Reports
Verified
Journal Article
Open access
OAOyindamola Adebayo
Oyindamola Adebayo
IBInge Bongaers
Inge Bongaers
ELElena Levtchenko
Elena Levtchenko
LHLambertus van Den Heuvel
Lambertus van Den Heuvel
VLVeerle Labarque
Veerle Labarque
The online version contains supplementary material available at 10.1038/s41598-026-41971-9.